Advertisement

June 17, 2013

Gaby L. Longsworth, Ph.D., Director

  • 202.772.8824
  • glongs@skgf.com
  • www.skgf.com
  •  

  • Gaby L. Longsworth, Ph.D., is a Director in the Biotechnology/Chemical Group. Dr. Longsworth's practice is focused on representing international and domestic generic pharmaceutical companies in patent cases involving Abbreviated New Drug Applications (ANDAs) that include a Paragraph IV (pIV) certification to one or more Orange Book listed patents. She is involved in multiple ANDA patent infringement cases brought under the Hatch-Waxman Act and has provided litigation and strategic advice concerning claim construction, invalidity and infringement issues, and expert reports, and prepared experts for depositions.

    In addition to her extensive litigation experience, Dr. Longsworth also has significant experience counseling generic clients on pIV filing strategies, including assessing the impact of data exclusivity, forfeiture issues (pre-MMA and post-MMA), label carve outs, and Patent Term Extensions (PTE). In addition, Dr. Longsworth has rendered hundreds of invalidity, noninfringement, freedom-to-operate, and patentability opinions in at least the following areas: therapeutic antibodies, API, polymorphs, crystal forms and salts, chemical synthesis, pharmaceutical formulations (including oral dosage forms, transdermal patches, injectables, ophthalmics, creams, gels, suspensions, and nasal and oral inhalation forms) and so-called pharmacokinetic (pK) patents. 

  • Sterne, Kessler, Goldstein & Fox P.L.L.C.

Articles in the National Law Review database by Gaby L. Longsworth, Ph.D.:

Boost: AJAX core statistics

Legal Disclaimer

You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. NLR does not accept advertising from attorneys or law firms. The National Law Review is not a law firm nor is www.NatLawReview.com  intended to be an advertisement or a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 

Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.